Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

Item

http://www.wikidata.org/entity/Q42505702

Q42505702

about

Evidence-Based Treatment Options in Recurrent and/or Metastatic Squamous Cell Carcinoma of the Head and Neck Immunotherapy in head and neck cancer: aiming at EXTREME precision.Screening candidate microRNA-mRNA regulatory pairs for predicting the response to chemoradiotherapy in rectal cancer by a bioinformatics approach The role of anti-EGFR agents in patients with locoregionally advanced head and neck cancer: a meta-analysis of randomized trials.Anti PD-L1 DUrvalumab combined with Cetuximab and RadiOtherapy in locally advanced squamous cell carcinoma of the head and neck: A phase I/II study (DUCRO).

P2860

Q33650470-8921AD63-8CCC-4E2B-A5DF-A24FF7922581 Q33756244-9F665372-B4D8-43ED-9CAA-DD8B319D4812 Q41197547-862C338D-BB0D-4A33-82B4-A09C60EAC953 Q47103766-3F494439-3BFB-4D26-BF05-CD347D5EB4E7 Q54982410-B5D76E99-6F5C-4F15-B3FC-08FC7269ADE2

P2860

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

Item

http://www.wikidata.org/entity/Q42505702

description

2017 nî lūn-bûn

@nan

2017年の論文

@ja

2017年学术文章

@wuu

2017年学术文章

@zh-cn

2017年学术文章

@zh-hans

2017年学术文章

@zh-my

2017年学术文章

@zh-sg

2017年學術文章

@yue

2017年學術文章

@zh

2017年學術文章

@zh-hant

name

Elevated basal antibody-depend ...... ith cetuximab and radiotherapy

@en

Elevated basal antibody-dependent cell-mediated cytotoxicity

@nl

type

Item

label

Elevated basal antibody-depend ...... ith cetuximab and radiotherapy

@en

Elevated basal antibody-dependent cell-mediated cytotoxicity

@nl

prefLabel

Elevated basal antibody-depend ...... ith cetuximab and radiotherapy

@en

Elevated basal antibody-dependent cell-mediated cytotoxicity

@nl

P1476

Elevated basal antibody-depend ...... ith cetuximab and radiotherapy

@en

P2093

Alberto Comino

http://www.w3.org/2001/XMLSchema#string

Daniela Vivenza

http://www.w3.org/2001/XMLSchema#string

Emmanuel Chamorey

http://www.w3.org/2001/XMLSchema#string

Gerard Milano

http://www.w3.org/2001/XMLSchema#string

Giuliana Strola

http://www.w3.org/2001/XMLSchema#string

Laura Lattanzio

http://www.w3.org/2001/XMLSchema#string

Marco Merlano

http://www.w3.org/2001/XMLSchema#string

Martino Monteverde

http://www.w3.org/2001/XMLSchema#string

Mirella Fortunato

http://www.w3.org/2001/XMLSchema#string

Nerina Denaro

http://www.w3.org/2001/XMLSchema#string

P2860

The role of NKT cells in tumor immunity

Prognosis of women with metastatic breast cancer by HER2 status and trastuzumab treatment: an institutional-based review

Putative contribution of CD56 positive cells in cetuximab treatment efficacy in first-line metastatic colorectal cancer patients

Evaluation of antibody-dependent cell-mediated cytotoxicity activity and cetuximab response in KRAS wild-type metastatic colorectal cancer patients.

Analysis of in vitro ADCC and clinical response to trastuzumab: possible relevance of FcγRIIIA/FcγRIIA gene polymorphisms and HER-2 expression levels on breast cancer cell lines.

Ex vivo antibody-dependent cellular cytotoxicity inducibility predicts efficacy of cetuximab

The relevance of ADCC for EGFR targeting: A review of the literature and a clinically-applicable method of assessment in patients.

Interferon-γ-induced PD-L1 surface expression on human oral squamous carcinoma via PKD2 signal pathway.

CD56-positive lymphocyte infiltration in relation to human papillomavirus association and prognostic significance in oropharyngeal squamous cell carcinoma.

P2888

s00262-017-1960-8

P304

573-579

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S00262-017-1960-8

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Cristiana Lo Nigro

Chiara Varamo

P577

2017-02-14T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P6179

1083823091

http://www.w3.org/2001/XMLSchema#string

P698

28197666

http://www.w3.org/2001/XMLSchema#string

P921

radiation therapy

cytotoxicity

cetuximab

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

about

P2860

P2860

Elevated basal antibody-dependent cell-mediated cytotoxicity (ADCC) and high epidermal growth factor receptor (EGFR) expression predict favourable outcome in patients with locally advanced head and neck cancer treated with cetuximab and radiotherapy

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P6179

P698

P921